ג'נואט 50500 מג XR טבליות ישראל - עברית - Ministry of Health

ג'נואט 50500 מג xr טבליות

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as phosphate salt - טבליות עם שחרור נרחב - sitagliptin as phosphate salt 50 mg; metformin hydrochloride 500 mg - metformin

ג'נואט 50500 מג XR טבליות ישראל - עברית - Ministry of Health

ג'נואט 50500 מג xr טבליות

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as phosphate salt - טבליות עם שחרור נרחב - sitagliptin as phosphate salt 50 mg; metformin hydrochloride 500 mg - metformin

Dry Salt inhalator - Saltmed ישראל - עברית - Ministry of Health

dry salt inhalator - saltmed

מדיגל בע"מ - כלל האוכלוסיה - אינהלציה ביתית

טייבסו ישראל - עברית - Ministry of Health

טייבסו

rafa laboratories ltd - treprostinil as sodium salt - תמיסה לשאיפה - treprostinil as sodium salt 1.74 mg / 2.9 ml - treprostinil - treprostinil - treatment of pulmonary arterial hypertension in patients with nyha class iii symptoms, to increase walk distance.

טורבה 10 ישראל - עברית - Ministry of Health

טורבה 10

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 10 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/

טורבה 20 ישראל - עברית - Ministry of Health

טורבה 20

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 20 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/

טורבה 40 ישראל - עברית - Ministry of Health

טורבה 40

unipharm ltd, israel - atorvastatin as calcium trihydrate salt - טבליה - atorvastatin as calcium trihydrate salt 40 mg - atorvastatin - atorvastatin - torid is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. torid is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/

טאזו-פיפ אבניר 4.5 גר' ישראל - עברית - Ministry of Health

טאזו-פיפ אבניר 4.5 גר'

bioavenir ltd, israel - piperacillin as sodium salt; tazobactam as sodium salt - אבקה להכנת תמיסה לזריקה - tazobactam as sodium salt 500 mg; piperacillin as sodium salt 4000 mg - tazobactam - tazobactam - antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms.tazo-pip avenir in combination with an aminoglycoside, is indicated for the treatment of suspected bacterial infections in neutropenic adults and children. appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

צפורוקסים - פרזניוס 750 מג ישראל - עברית - Ministry of Health

צפורוקסים - פרזניוס 750 מג

neopharm (israel) 1996 ltd - cefuroxime as sodium salt - אבקה להכנת תמיסה לזריקה - cefuroxime as sodium salt 750 mg - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible micro-organisms

צפורוקסים - פרזניוס 1500 מג ישראל - עברית - Ministry of Health

צפורוקסים - פרזניוס 1500 מג

neopharm (israel) 1996 ltd - cefuroxime as sodium salt - אבקה להמסה להזרקה\אינפוזיה - cefuroxime as sodium salt 1500 mg - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible micro-organisms